NEW YORK, Sept. 13 (GenomeWeb News) - Atugen said today that it has formed a collaboration with Aventis to identify siRNA compounds that have potential for development as therapeutics.
Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.
